Compare GLP-1

Provider review · Source record 2026-10-05

Cora Health review

Cora names its annual charge and monthly alternative, making commitment visible.

Editorial source record

Cora Health: Cora names its annual charge and monthly alternative, making commitment visible.

Cora’s homepage identifies the $99 monthly equivalent as $1,188 billed every twelve months, renewing until canceled. It gives $175 as the semaglutide month-to-month option and advertises tirzepatide from $135 on an annual term.

Cora Health offer and care questions — illustrated reading map
An original reading map for this article. It organizes the questions; it does not depict patient results.

The annual amount is visible on the current page

Cora’s homepage identifies the $99 monthly equivalent as $1,188 billed every twelve months, renewing until canceled. It gives $175 as the semaglutide month-to-month option and advertises tirzepatide from $135 on an annual term.

That makes it possible to distinguish the annual commitment from a flexible monthly payment. Before choosing, ask how cancellation affects already paid amounts and what happens if treatment changes.

Published names are a starting point for verification

The current page identifies pharmacy partners and describes clinician review, shipping and support as included. Naming a pharmacy is useful because a reader can check the assigned dispenser directly; it is not a guarantee of every prescription’s quality or outcome.

Ask which partner will fill the selected order, how to contact that pharmacy and who handles clinical follow-up. This review does not claim an independent licensing audit or a completed patient transaction.

How to use this source review

This Cora Health record is an editorial reading of the linked public material checked on October 5, 2026. It identifies the offer details visible there and the questions a prospective customer still needs answered. It does not report a patient interview, a prescription purchase or a clinical assessment.

Keep the Cora Health source date with your notes. The source can change after publication, and an individual agreement may differ from a general landing page. Compare the provider’s written answer with the other records on this site rather than interpreting our directory position as a patient rating.

The service record

Medication scope
Compounded semaglutide and tirzepatide

Costs and commitments

Advertised program
Semaglutide $1,188/year ($99/month equivalent) or $175 month to month
Medication
Use the selected prescription and full payment quote.
Insurance
Confirm the selected service and benefit conditions.
Put your selected quote into the cost worksheet →

What stands out, and what to clarify

Published features

  • The annual amount is visible on the current page
  • Published names are a starting point for verification

Questions and limits

  • We have not tested the clinical service, fulfillment or refund process.
  • General website terms do not establish personal eligibility.

Before you proceed

  1. Review the dated source and selected service.
  2. Confirm clinician, pharmacy and complete quote.
  3. Save the recurring-payment and cancellation terms.

Confirm these details with the selected provider. Response times, approval and fulfillment were not tested for this review.

Sources and review boundaries

Source record: 2026-10-05. Provider descriptions document advertised services. They do not establish patient outcomes or independent verification of every operational claim.

Editorial information, not a personal treatment recommendation. Prescription decisions require a licensed clinician. Compounded preparations do not carry FDA approval.